• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Breckenridge Announces Final Approval of its ANDA for Rivastigmine

    PR NEWSWIRE

    Enforcement Report - Week of April 12, 2017

    FDA

    Cadila Pharms Ltd`s Generic Rivastigmine Tartrate Receives Approval In US

    FDA

    Aurobindo Pharma`s Generic Rivastigmine Tartrate approved in US for alzheimer

    FDA

    Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate

    PHARMA-EXCIPIENTS

    Dr Reddy`s Lab slips on recall of Rivastigmine Tartrate Capsules from USA

    BUSINESS STANDARD

    Orchid`s Generic Rivastigmine Tartrate (1.5, 3, 4.5, 6 Mg Base) Approved in US For Alzheimer

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.